Jump to section
To help people get their medications quickly, easily and affordably.
Specialty pharmaceuticals are used to treat conditions such as hepatitis C, cancer, rheumatoid arthritis, and Crohn’s disease, with a global market estimated to be worth more than $30 billion. These drugs represent a significant portion of US prescription medication spend, although patients and their care teams are often faced with roadblocks in access and affordability.
Phil is a company offering a solution to these issues with its suite of software tools that help simplify the complex and scattered workflow involving patients, prescribers, pharmacies and manufacturers. It takes into account the fact that giving patients consistent access to recurring medications can’t be solved by fixing just one point in the system.
The platform is used by thousands of healthcare providers and patients across all 50 states, including at some of the largest pharmaceutical companies across the US. Having received significant funding and sustained growth, it is focused on further developing its platform and expanding its marketing reach.
Kirsty
Company Specialist at Welcome to the Jungle
Jun 2021
$56m
SERIES D
May 2019
$25m
SERIES B
This company has top investors
Deepak Thomas
(CEO)Received an MBA from the University of Chicago, and was a Senior Product Manager at Oracle. Was GM, Global Mobile Products at eBay. Moved to Shutterfly in 2012, before founding Phil in 2015.